Neoplasms: all 9,617 studies

Page 54 of 97. Open to participants first (2,509), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of JMT101 in Patients With Advanced Solid TumorStatus unknownNCT04689100Phase 1
• Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002).CompletedNCT04687982Not applicable
• Study of FCN-011 in Patients With Advanced Solid Tumor（Phase I）and NTRK Fusion Positive Advanced Solid Tumor （Phase II）Status unknownNCT04687423Phase 1
• Safety, Tolerability, and Pharmacokinetics of CAL056 Mesylate in Patients With Resistant or Refractory Solid TumorsCompletedNCT04686383Phase 1
• Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid MalignanciesWithdrawnNCT04684979Phase 2
• Study of HL-085 in Patients With Advanced Solid Tumor TumorsCompletedNCT04683354Phase 1
• CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLCCompletedNCT04681131Phase 2
• A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid TumorsStatus unknownNCT04679038Phase 1/2
• First-in-Human Study of INT-1B3 in Patients With Advanced Solid TumorsTerminatedNCT04675996Phase 1
• CORE: CO Monitoring for Reach and Efficacy in Tobacco Treatment for Cancer PatientsCompletedNCT04675515Not applicable
• A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid TumorsActive, not recruitingNCT04673942Phase 2
• Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid TumorStatus unknownNCT04673396Phase 1
• Cognitive Status Assessment In Elderly Patients With Active Treatment For Haematological MalignanciesStatus unknownNCT04673305Not applicable
• Usefulness of GI-GENIUS in FIT-based Colorectal Cancer Screening Program.CompletedNCT04673136Not applicable
• Treatment of Malignant Tumors With Antigen Peptide-specific DC-CTL Cells and DecitabineStatus unknownNCT04672473Phase 1/2
• Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesCompletedNCT04672434Phase 1
• A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid TumorsCompletedNCT04670679Phase 1
• SARS-CoV-2 Donor-Recipient Immunity TransferCompletedNCT04666025
• A Study of SGN-STNV in Advanced Solid TumorsTerminatedNCT04665921Phase 1
• Predictive Value of Ariscat Index In The Development of Pulmonary Complication After Major Abdominal Cancer SurgeryCompletedNCT04663958
• An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving UdenycaStatus unknownNCT04662892
• CAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsActive, not recruitingNCT04660929Phase 1
• NL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory CancerCompletedNCT04659629Phase 1
• A Study of ION537 in Patients With Molecularly Selected Advanced Solid TumorsCompletedNCT04659096Phase 1
• Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma PatientsCompletedNCT04657315Phase 1/2
• Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With MalignancyCompletedNCT04657120Not applicable
• Immuno-Oncology Database and BioregistryCompletedNCT04656873
• NOURISH-T+: Promoting Healthy Eating and Exercise BehaviorsActive, not recruitingNCT04656496Not applicable
• A Study to Test Different Doses of BI 765063 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer (Solid Tumors)CompletedNCT04653142Phase 1
• Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID StudyCompletedNCT04652505
• CART Therapy in GUCY2C-positive Digestive Tract TumorsCompletedNCT04652219Early Phase 1
• Functional Outcomes of Knee Protheses for Malignant Tumours of BoneCompletedNCT04650594Not applicable
• Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing MalignanciesCompletedNCT04649112Phase 1
• Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial MalignanciesWithdrawnNCT04648826Phase 1/2
• Surgery for Locally Advanced Colon Cancer: is it Worth it? A Multicenter Retrospective Analysis.Status unknownNCT04646772
• ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid TumorsCompletedNCT04645069Phase 1/2
• Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell CarcinomaStatus unknownNCT04644432Phase 2
• NeoTIL in Advanced Solid TumorsActive, not recruitingNCT04643574Phase 1
• Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor MalignanciesCompletedNCT04641871Phase 1
• Care Transition Intervention for Patients With CancerCompletedNCT04640714Not applicable
• Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard TherapiesStatus unknownNCT04640246Phase 1/2
• ARGONAUT: Stool and Blood Sample Bank for Cancer PatientsSuspendedNCT04638751
• Optimized Psycho-oncological Care Through an Interdisciplinary Care AlgorithmStatus unknownNCT04638699Not applicable
• Safety Tolerability Pharmacokinetic and Preliminary Efficacy in Chinese Advanced Solid Tumors PatientsCompletedNCT04638491Phase 1
• Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19CompletedNCT04637295
• Supportive Oncology Care at Home Post-DischargeCompletedNCT04637035Not applicable
• A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid NeoplasmsTerminatedNCT04637009Phase 1
• Phase 1 Trial of LVGN7409 (CD40 Agonist Antibody) as Single Agent and Combination Therapies in Advanced or Metastatic MalignancyCompletedNCT04635995Phase 1
• Outcomes in Patients With Myeloproliferative Neoplasm and Splanchnic Vein ThrombosisStatus unknownNCT04631458
• Captopril Use on the Degree of Marrow Fibrosis in Bone Marrow Fibrosis/Myeloproliferative NeoplasmsWithdrawnNCT04629651Phase 1/2
• Personalized Vaccine With SOC Chemo Followed by Nivo in Pancreatic CancerActive, not recruitingNCT04627246Phase 1
• Clinical Study of Targeting CD19 and CD22 Chimeric Antigen Receptor T Lymphocytes in the Treatment of Recurrent or Refractory B Cell Non-Hodgkin LymphomaStatus unknownNCT04626908Phase 1/2
• International Study to Evaluate Two Programs of Support for Patients With Advanced Cancer and Their FamiliesCompletedNCT04626349Not applicable
• Patient Perspective of Telemedicine in Gynecology OncologyCompletedNCT04624165
• A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2618 Injection in Subjects With Advanced Solid TumorsStatus unknownNCT04623892Phase 1
• Responsible Side Effects Management in OncologyCompletedNCT04623437
• Prevalence of Sub-epithelial Lesions Among Patients Undergoing EGDs in EgyptStatus unknownNCT04622098
• Construal Level as a Novel Pathway for Affect Regulation and Cancer ControlCompletedNCT04620915Not applicable
• Longitudinal Analysis of Mental Disorders, Psychosocial Distress and Care Needs of Patients and Their RelativesActive, not recruitingNCT04620564
• Safety and Effectiveness of Radiofrequency Ablation System in the Treatment of Peripheral Lung TumorsCompletedNCT04619472Not applicable
• Anticoagulation in Patients With Venous Thromboembolism and CancerCompletedNCT04618913
• A Study of EMB-02 in Participants With Advanced Solid TumorsTerminatedNCT04618393Phase 1/2
• A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine TumorsWithdrawnNCT04614766Phase 1/2
• The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid TumorsStatus unknownNCT04614740Phase 1/2
• TEMOkids Study : A Phase I Pediatric Study for KIMOZO, Oral Suspension of TemozolomideCompletedNCT04610736Phase 1
• A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid MalignanciesActive, not recruitingNCT04606381Phase 1
• Decision Aid to Support Advanced Cancer PatientsStatus unknownNCT04606238Not applicable
• The Integrated Support and Palliative in Cancer Day-care Hospital for Patients With Advanced Cancers: Impact on Quality of Life, Care Pathways and Support for Caregivers (HDJ-SPI)CompletedNCT04604873Not applicable
• ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic CancerWithdrawnNCT04602117Phase 1
• GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALLTerminatedNCT04601584Phase 1/2
• A Phase I Study of JS108 in Patients With Advanced Solid TumorsTerminatedNCT04601285Phase 1
• Safety and Efficacy of ThisCART22 in Patients With Refractory or Relapsed B Cell MalignanciesStatus unknownNCT04601181Phase 1
• Existential Distress in Patients with Advanced Cancer and Their CaregiversCompletedNCT04600206
• The Gut Immune System During Immune Checkpoint Inhibitor TherapyActive, not recruitingNCT04600180
• Real-time Detection of ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT04599309
• The Harmonized Interventions to Maintain Health Via Appropriate Risk Factor Modification and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Pilot StudyCompletedNCT04598646Not applicable
• Personalised Disease Monitoring in Metastatic Breast CancerActive, not recruitingNCT04597580
• A Study of AK112 for Advanced Solid TumorsCompletedNCT04597541Phase 1/2
• Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate CancerActive, not recruitingNCT04597411Phase 1
• Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast CancerCompletedNCT04596150Phase 2
• Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for Colorectal Laterally Spreading Lesions.Active, not recruitingNCT04593407Not applicable
• Less Frequent IV Dosing & Tumor Microenvironment (TME) Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy and in Combination With Pembrolizumab (ARTISTRY-3)Active, not recruitingNCT04592653Phase 1/2
• A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid TumorsCompletedNCT04592484Phase 1/2
• Study of SHR2150 (TLR7 Agonist) in Combination With Chemotherapy Plus PD-1 or CD47 Antibody in Subjects With Unresectable/ Metastatic Solid TumorsStatus unknownNCT04588324Phase 1/2
• The Impact of Pecs Blocks on Postmastectomy Pain SyndromeCompletedNCT04586751Not applicable
• A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor CancerTerminatedNCT04586270Phase 1
• Stereotactic Radiosurgery With Abemaciclib, Ribociclib, or Palbociclib in Treating Patients With Hormone Receptor Positive Breast Cancer With Brain MetastasesWithdrawnNCT04585724Phase 1
• Study to Evaluate D-1553 in Subjects With Solid TumorsActive, not recruitingNCT04585035Phase 1/2
• Stockholm3 Validation Study in a Multi-Ethnic CohortCompletedNCT04583072
• Efficacy Assessment of a Novel 3D Cartography-based Targeted Focal Microwave Therapy in Men With Localized Intermediate-risk Prostate CancerCompletedNCT04582656Not applicable
• An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic MalignanciesStatus unknownNCT04581187
• GO SOAR1: Post-Operative Morbidity and Mortality Following Gynaecological Oncology SurgeryStatus unknownNCT04579861
• First-In-Human Phase I Trial of Ningetinib ( CT053PTSA ) in the Patients With Advanced Solid TumorsCompletedNCT04577703Phase 1
• Lidocaine And Neuromonitoring in Thyroid SurgeryCompletedNCT04574947Phase 4
• Gastric Cancer Liver Metastasis Cohort of ChinaStatus unknownNCT04574245
• Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and MelanomaActive, not recruitingNCT04572451Phase 1
• A Study of AK119 (Anti-CD73) in Combination With AK104 in Subjects With Advanced Solid TumorsCompletedNCT04572152Phase 1
• A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid TumorsStatus unknownNCT04571892Phase 1/2
• Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid TumorsStatus unknownNCT04569916Phase 2
• Mobile Application Using the PRO-CTCAE to Improve Patients' Participation in Symptom Management During Treatment.CompletedNCT04568278Not applicable

← Neoplasms overview